Applied Optoelectronics (AAOI) stock jumps nearly 18% on Oxford Instruments Texas expansion deal

Applied Optoelectronics (AAOI) stock jumps nearly 18% on Oxford Instruments Texas expansion deal

New York, Jan 28, 2026, 13:01 (EST) — Regular session

  • Applied Optoelectronics shares jumped roughly 18%, hitting $44.05 in midday trading
  • Oxford Instruments announced it will provide plasma etch and deposition systems to AOI’s facility in Sugar Land, Texas
  • Investors are focused on today’s Fed decision, looking for its impact on rate-sensitive tech stocks

Applied Optoelectronics Inc shares surged nearly 18% on Wednesday following Oxford Instruments’ announcement that it secured a plasma equipment supply deal linked to the U.S. optical components firm’s expansion in Texas. By 12:45 p.m. EST, the stock had climbed roughly 17.8% to $44.05, hitting a session high of $44.25.

This announcement hits differently because investors see anything connected to AI data-center expansions as a high-voltage trigger. For small-to-midcap suppliers, fresh capacity plans often send shares jolting more than any spreadsheet forecast could.

Oxford Instruments announced it will provide several etch and deposition “cluster” systems to Applied Optoelectronics’ facility in Sugar Land, Texas. The move supports AOI’s push to scale up indium phosphide production for optoelectronic devices. Fred Chang, an AOI executive, said the expansion targets “demand for our optical transceivers in AI data centers,” noting the new tools could boost quality and cut costs. Emiel Thijssen from Oxford Instruments called AOI “a valued long-term partner.” semiconductor-today.com

The rally pushed AAOI past several competitors today. Viavi Solutions climbed around 3.0%, Lumentum Holdings rose close to 2.9%, and Coherent eked out a 0.9% gain. Fabrinet, however, dipped about 1.4%.

A regulatory filing earlier this week revealed that AOI’s CFO, Stefan J. Murry, handed over 7,150 shares on Jan. 22 to cover tax withholding related to vested restricted stock units, opting not to sell them on the open market. The Form 4 was signed and submitted on Jan. 26.

Etch and deposition are the chipmaking steps often described as “cut” and “coat”: etch removes material from the wafer, while deposition deposits ultra-thin layers. Indium phosphide, a compound semiconductor, finds use in lasers and high-speed optical components—a niche gaining traction as data centers race toward faster connections.

Applied Optoelectronics develops and markets fiber-optic networking gear, such as optical modules and lasers, for broadband and data-center applications.

The broader market lent support as well. Chip-related shares held steady Wednesday, with Wall Street gearing up for big tech earnings and the Federal Reserve’s policy decision.

But there’s the usual caveat. Equipment supply agreements don’t guarantee immediate revenue, and installation plus qualification can take time—especially when manufacturers adopt new wafer sizes or automation processes. A slowdown in AI-related spending would quickly challenge the bullish outlook.

Turning to macro, the Fed’s statement drops at 2 p.m. EST, with Chair Jerome Powell speaking at 2:30 p.m. This slot often rattles high-growth tech stocks, even when no rate change is anticipated.

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Constellation Energy

NASDAQ: CEG 94 / 100
#3 BUY ON PULLBACK

Cheniere Energy

NYSE: LNG 92 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

AIG

NYSE: AIG 88 / 100
View full portfolio
Editorial model selection. Not personalised advice.
CVS stock rebounds after Medicare Advantage rate shock; what investors watch next
Previous Story

CVS stock rebounds after Medicare Advantage rate shock; what investors watch next

Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week
Next Story

Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week